ClinicalTrials.gg
CompletedNCT07873385Updated Oct 14, 2026

Evaluation of MTHFR Gene Polymorphism and Periodontal Clinical Parameters in Healthy, Hypertensive, and Periodontitis Individuals

An observational study in Hypertension and Periodontitis, sponsored by Akdeniz University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by Akdeniz University · Observational

Updated Oct 14, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

This observational study aims to evaluate the relationship between MTHFR gene polymorphisms and periodontal clinical findings in healthy individuals, individuals with hypertension, individuals with periodontitis, and individuals with both hypertension and periodontitis. A total of 200 participants will be included in four groups of 50 participants each. Periodontal clinical measurements, including plaque index, gingival index, bleeding on probing, probing depth, and clinical attachment level, will be recorded. Venous blood samples will be collected for DNA isolation and analysis of MTHFR gene polymorphisms. The study will investigate whether MTHFR gene polymorphisms are associated with periodontal clinical parameters and hypertension.

Read the detailed description

This is a single-center observational study conducted at the Department of Periodontology, Faculty of Dentistry, Akdeniz University. The study includes four groups: healthy individuals, individuals with hypertension without periodontitis, individuals with periodontitis without hypertension, and individuals with both hypertension and periodontitis. A total of 200 participants will be included, with 50 participants planned for each group.

Periodontal clinical parameters will be assessed using a periodontal probe and will include plaque index, gingival index, bleeding on probing, probing depth, clinical attachment level, and gingival recession. Periodontal status will be classified according to the 2018 EFP/AAP classification. Venous blood samples will be collected from the participants, followed by DNA isolation and molecular analysis of MTHFR gene polymorphisms using polymerase chain reaction (PCR)-based methods.

The study population will consist of adults aged 18 years or older. Participants will be required to be nonsmokers, have no periodontal treatment within the previous six months, and have no systemic disease affecting periodontal health other than hypertension. Individuals with tuberculosis, hepatitis, or AIDS and pregnant individuals will not be included.

The study aims to evaluate the association between MTHFR gene polymorphisms, hypertension, and periodontal clinical parameters. Statistical analyses will be performed using appropriate statistical methods, with statistical significance set at p \< 0.05.

02

Conditions studied

  • Hypertension
  • Periodontitis

Keywords

  • MTHFR gene polymorphism
  • Periodontal clinical parameters
  • Periodontitis
  • Hypertension
  • Periodontal disease
03

In context

Hypertension

6,834 studies on the registry are indexed under Hypertension; 971 are open to participants now.

This study's enrollment of 200 is close to the median of 210 across 1,392 observational studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Akdeniz University is the lead sponsor of 296 studies on the registry; 62 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adults aged 18 years or older who meet the eligibility criteria will be included in the study. A total of 200 participants will be included in four groups: healthy individuals, individuals with hypertension, individuals with periodontitis, and individuals with both hypertension and periodontitis, with 50 participants in each group. Participants will undergo periodontal clinical examination and venous blood sampling for MTHFR gene polymorphism analysis.

Eligibility criteria

Inclusion Criteria:

  • Age 18 years or older.
  • Nonsmokers.
  • No periodontal treatment within the previous 6 months.
  • No systemic disease affecting periodontal health other than hypertension.
  • No tuberculosis, hepatitis, or AIDS.
  • Not pregnant.

Exclusion Criteria:

Inclusion Criteria:

  • Age 18 years or older.
  • Nonsmokers.
  • No periodontal treatment within the previous 6 months.
  • No systemic disease affecting periodontal health other than hypertension.
  • No tuberculosis, hepatitis, or AIDS.
  • Not pregnant.

Exclusion Criteria:

none

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
200 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Healthy Individuals

    This group consists of 50 healthy individuals without hypertension or periodontitis. Participants will undergo periodontal clinical examinations and venous blood sampling for MTHFR gene polymorphism analysis.

    Other: MTHFR Gene Polymorphism Analysis

  • Individuals with Hypertension

    This group consists of 50 individuals with hypertension without periodontitis. Participants will undergo periodontal clinical examinations and venous blood sampling for MTHFR gene polymorphism analysis.

    Other: MTHFR Gene Polymorphism Analysis

  • Individuals with Periodontitis

    This group consists of 50 individuals with periodontitis without hypertension. Participants will undergo periodontal clinical examinations and venous blood sampling for MTHFR gene polymorphism analysis.

    Other: MTHFR Gene Polymorphism Analysis

  • Individuals with Hypertension and Periodontitis

    This group consists of 50 individuals with both hypertension and periodontitis. Participants will undergo periodontal clinical examinations and venous blood sampling for MTHFR gene polymorphism analysis.

    Other: MTHFR Gene Polymorphism Analysis

Interventions

  • OtherMTHFR Gene Polymorphism Analysis

    Participants will undergo venous blood sampling, DNA isolation, and analysis of MTHFR gene polymorphisms. No therapeutic intervention is assigned to participants; the study is observational.

06

What researchers measure

Primary outcomes

  1. Plaque Index (Silness & Löe)

    Dental plaque accumulation assessed using the Silness \& Löe Plaque Index. Scores range from 0 to 3; higher scores indicate greater plaque accumulation

    Time frame: At baseline periodontal examination

  2. Gingival Index (Löe & Sillnes)

    Gingival inflammation assessed using the Löe \& Silness Gingival Index. Scores range from 0 to 3; higher scores indicate more severe inflammation.

    Time frame: At baseline periodontal examination

  3. Bleeding on Probing (BOP)

    Percentage of sites showing bleeding within 30 seconds after gentle probing. Reported as percentage of examined sites (%).

    Time frame: At baseline periodontal examination

  4. Probing Depth (PD)

    Distance from the gingival margin to the base of the periodontal pocket, measured with a periodontal probe at six sites per tooth. Reported as mean value in millimeters (mm).

    Time frame: At baseline periodontal examination

  5. Clinical Attachment Level (CAL)

    Distance from the cemento-enamel junction to the base of the periodontal pocket, measured at six sites per tooth. Reported as mean value in millimeters (mm).

    Time frame: At baseline periodontal examination

07

Study locations

1 site
  • Akdeniz University Faculty of Dentistry, Department of Periodontology
    Antalya, Antalya 07058, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07873385
Lead sponsor
Akdeniz University
Responsible party
Sponsor
First posted
Oct 14, 2026
Start date
Mar 27, 2026
Primary completion
Sep 27, 2026
Completion
Sep 27, 2026
Last update
Oct 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion